Barbara A. Pelak

1.2k citations
28 papers · 939 indexed · h-index 14
Topics
Antibiotics Pharmacokinetics and Efficacy (20 papers)Antibiotic Resistance in Bacteria (13 papers)Drug Transport and Resistance Mechanisms (4 papers)
Partner nations
United StatesJapan

In The Last Decade

Barbara A. Pelak

28 papers receiving 866 citations

Peers

Barbara A. Pelak
Comparison fields: 5 of 76
  • Molecular Biology 329
  • Pharmacology 302
  • Molecular Medicine 241
  • Infectious Diseases 205
  • Epidemiology 180
Replace Magdalena Zalacaín with:
Magdalena Zalacaín United States
Raúl Goldschmidt United States
W. TOSCH Switzerland
K. Coleman United States
Alain Bonnefoy France
J. Allan Waitz United States
S. Pearson United States
M. S. Marriott United Kingdom
Paul Actor United States
K. E. Price United States
Barbara A. Pelak relative to Magdalena Zalacaín United States Magdalena Zalacaín's profile →
Citations per field
00.5×1.5×
Magdalena Zalacaín · 1×
Citations per year

Countries citing papers authored by Barbara A. Pelak

Since Specialization
Citations

This map shows the geographic impact of Barbara A. Pelak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Pelak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Pelak more than expected).

Fields of papers citing papers by Barbara A. Pelak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Pelak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Pelak. The network helps show where Barbara A. Pelak may publish in the future.

Co-authorship network of co-authors of Barbara A. Pelak

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Pelak. A scholar is included among the top collaborators of Barbara A. Pelak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Pelak. Barbara A. Pelak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 15
3 18
4 18
5 57
6 39
7 3
8 3
9 4
10 1
11 2
12 79
13 49
14 1
15 22
16 2
17 4
18 1
19 33
20 11

About Barbara A. Pelak

Barbara A. Pelak is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 28 papers that have together received 939 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (13 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Molecular Medicine (241 citations), Pharmacology (302 citations) and Applied Microbiology and Biotechnology (36 citations). Barbara A. Pelak has collaborated with scholars based in United States and Japan. Frequent co-authors include H Kropp, Arthur A. Patchett, Matt S. Anderson, Susan Galloway, Meng‐Hsin Chen, Frederick M. Kahan, Sheryl A. Hyland, Christian R.H. Raetz, Lynn L. Silver and Hiroshi Ōnishi. Their work appears in journals such as Science, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026